Literature DB >> 11698994

Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection.

J W Gow1, K Simpson, P O Behan, A Chaudhuri, I C McKay, W M Behan.   

Abstract

Gene expression of key enzymes in 2 antiviral pathways (ribonuclease latent [RNase L] and RNA-regulated protein kinase [PKR]) was compared in 22 patients with chronic fatigue syndrome (CFS), 10 patients with acute gastroenteritis, and 21 healthy volunteers. Pathway activation in the group of patients with infections differed significantly from that of the other 2 groups, in whom there was no evidence of upregulation. Therefore, assay of activation is unlikely to provide the basis for a diagnostic test for CFS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11698994     DOI: 10.1086/324357

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

Review 1.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

2.  RNase L levels in peripheral blood mononuclear cells: 37-kilodalton/83-kilodalton isoform ratio is a potential test for chronic fatigue syndrome.

Authors:  Kiet Phong Tiev; Edith Demettre; Philippe Ercolano; Lionel Bastide; Bernard Lebleu; Jean Cabane
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

3.  Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions.

Authors:  Timothy J Henrich; Jonathan Z Li; Donna Felsenstein; Camille N Kotton; Robert M Plenge; Florencia Pereyra; Francisco M Marty; Nina H Lin; Paul Grazioso; Danielle M Crochiere; Daniel Eggers; Daniel R Kuritzkes; Athe M N Tsibris
Journal:  J Infect Dis       Date:  2010-10-11       Impact factor: 5.226

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.